DO SPECIALTY DRUGS OFFER LARGER POPULATION HEALTH BENEFITS THAN NON-SPECIALTY DRUGS?
Abstract
Authors
T. Thorat C. Wilkinson J. Chambers P.J. Neumann
T. Thorat C. Wilkinson J. Chambers P.J. Neumann
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now